Citation Impact
Citing Papers
Conversion of amyloid positive and negative MCI to AD over 3 years
2009
Science faculty’s subtle gender biases favor male students
2012 Standout
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
2009
Exercise training increases size of hippocampus and improves memory
2011 Standout
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
2009 StandoutScience
Cerebrospinal fluid tau and ptau 181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
2009
Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011
Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
2015
The independent contribution of executive functions to health related quality of life in older women
2010
Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta‐analysis
2008
Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
2012
Cerebrovascular disease, beta-amyloid, and cognition in aging
2011
2013 Alzheimer's disease facts and figures
2013 Standout
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
2008
Alzheimer Mechanisms and Therapeutic Strategies
2012
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease
2011
Analysis of the episodic memory deficit in early Alzheimer's disease: Evidence from the doors and people test
1996
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
2001 Standout
Memantine for the treatment of dementia
2003
Cognitive Test Performance in a Community-Based Nondemented Elderly Sample in Rural India: The Indo-U.S. Cross-National Dementia Epidemiology Study
1996
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
2012
Associations of Gait Speed and Other Measures of Physical Function With Cognition in a Healthy Cohort of Elderly Persons
2007
Delirium in elderly people
2013 Standout
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
2005
Alzheimer's disease
2011 Standout
Amyloid imaging in mild cognitive impairment subtypes
2009
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
2011
Hemispheric asymmetry reduction in older adults: The HAROLD model.
2002 Standout
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer’s Disease Trials: An AIBL Study
2015 StandoutNobel
Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
2011
Mild Cognitive Impairment
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Practice guideline update summary: Mild cognitive impairment [RETIRED]
2017 Standout
-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
2007
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
2014
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
2010
Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study
2006
Monetary Costs of Dementia in the United States
2013 Standout
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
2005
Depression in Late Life: Review and Commentary
2003 Standout
Systematic review of health behavioral risks and cognitive health in older adults
2009
The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub‐syndromes and the influence of clinical variables
2005
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
2002
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Incidental Findings on Brain MRI in the General Population
2007 Standout
FSL
2011 Standout
Cognitive Reserve and Alzheimer’s Disease
2014
Relationship between Memory Performance and β-Amyloid Deposition at Different Stages of Alzheimer’s Disease
2012
Parkinson's disease
2015 Standout
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial
2008
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
2013 Standout
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
2010
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
2008
In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older Adults
2011
Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
2009
Brain Amyloid Imaging
2011
Cognition, reserve, and amyloid deposition in normal aging
2009
Regional brain hypometabolism is unrelated to regional amyloid plaque burden
2015
Early-Life Risk Factors for Alzheimer Disease
2006
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Apolipoprotein E Genotype, Vascular Risk and Early Cognitive Impairment in an African Caribbean Population
2001
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Psychomotor Speed and Functional Brain MRI 2 Years After Completing a Physical Activity Treatment
2010
Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study
2006
Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
2009
Alzheimer's Disease
2010 Standout
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal
2004
Donepezil for the Treatment of Agitation in Alzheimer's Disease
2007
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
2009
The Amyloid State of Proteins in Human Diseases
2012 Standout
A Double-Blind Comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia
2007
Alcohol Consumption as a Risk Factor for Dementia and Cognitive Decline: Meta-Analysis of Prospective Studies
2009
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
2009
Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
2011
Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease
2011
Alzheimer's Disease
2004 Standout
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
2009
Amyloid‐β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease
2010
Health outcomes of bereavement
2007 Standout
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
2011
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
2010
Ecology of the Aging Human Brain
2011
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 Standout
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Influence of population versus convenience sampling on sample characteristics in studies of cognitive aging
2013
Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects
2002
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
2009 Nature
Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil
2004
<emph type="ital">Ginkgo biloba</emph> for Preventing Cognitive Decline in Older Adults<subtitle>A Randomized Trial</subtitle>
2009
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications
2007
Gait Speed and Survival in Older Adults
2011 Standout
The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI
2013
Regional Brain Changes in Aging Healthy Adults: General Trends, Individual Differences and Modifiers
2005 Standout
Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples
2006
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype
2018
Lecanemab in Early Alzheimer’s Disease
2022 Standout
In vivo mapping of amyloid toxicity in Alzheimer disease
2009
The Preclinical Alzheimer Cognitive Composite
2014
Sex Differences in Brain Gray and White Matter in Healthy Young Adults: Correlations with Cognitive Performance
1999
Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study–Cognition Study
2012
Physical function trajectories, depressive symptoms, and life satisfaction among the elderly in Taiwan
2009
Hemispheric asymmetry reduction in older adults: The HAROLD model.
2002 Standout
Memantine for dementia
2006
Depression in the elderly
2005
Executive Functions
2012 Standout
APOE ɛ4 and Low Cholesterol as Risks for Depression in a Biracial Elderly Community Sample
2002
Delirium in the acute phase after stroke: incidence, risk factors, and outcome.
2011
Navigation-related structural change in the hippocampi of taxi drivers
2000 Standout
Amyloid imaging in dementias with atypical presentation
2012
Amyloid, hypometabolism, and cognition in Alzheimer disease
2006
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
2012
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
2008
Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span
2015
Donepezil for dementia due to Alzheimer's disease
2006
Mild cognitive impairment, amnestic type
2004
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve
2009
Emerging Targets in Photopharmacology
2016 StandoutNobel
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
2010
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
2012
The Science of Sex Differences in Science and Mathematics
2007
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
2006
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
2011
Works of Judith Saxton being referenced
Factors associated with adherence to medication regimens in older primary care patients: The steel valley seniors survey
2008
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
2008
Prevalence of Mild Cognitive Impairment by Multiple Classifications: The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) Project
2010
Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches
2013
The relation of White Matter Hyperintensities to implicit learning in healthy older adults
2002
Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment
2002
Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms
2000
Relationship of Deep White Matter Hyperintensities and Apolipoprotein E Genotype to Depressive Symptoms in Older Adults Without Clinical Depression
2001
Event-related functional magnetic resonance imaging investigation of executive control in very old individuals with mild cognitive impairment
2005
Cognitive Domains and Trajectories of Functional Independence in Nondemented Elderly Persons
2006
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
2009
Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B
2008
Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities
2013
Detection and Management of Cognitive Impairment in Primary Care: The Steel Valley Seniors Survey
2004
Maintenance of Mobility in Residents of an Alzheimer Special Care Facility
1998
Outcomes of Mild Cognitive Impairment by Definition
2011
Sex Differences in Brain Aging
1998
Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve
2009
The Ginkgo Evaluation of Memory (GEM) study: Design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia
2006
O3‐12‐03: Why we need two cutoffs for amyloid imaging: Early versus Alzheimer's‐like amyloid‐positivity
2012
Normal Rates of Forgetting of Verbal and Non-Verbal Material in Alzheimer's Disease
1987
Serum anticholinergic activity, white matter hyperintensities, and cognitive performance
2005
Alcohol consumption and cognitive function in late life
2005
Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia
2013
Relation of education to brain size in normal aging
1999
The Severe Impairment Battery
1997
Cognitive Correlates of Human Brain Aging
2001
Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery.
1990
The Long-Term Effects of Conventional and Atypical Antipsychotics in Patients With Probable Alzheimer’s Disease
2013
Patterns of Change in the Treatment of Psychiatric Symptoms in Patients With Probable Alzheimer's Disease From 1983 to 2000
2003
Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study
2009
Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease
2000
Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery.
1990
In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects
2012
Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II
2000
Psychiatric Symptoms Vary With the Severity of Dementia in Probable Alzheimer's Disease
2003